Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres).
Saved in:
| Title: | Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres). |
|---|---|
| Authors: | Mattiolo P; Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Piazzale L.A. Scuro, 10, 37134, Verona, Italy., Bevere M; ARC-NET Applied Research On Cancer Center, University of Verona, Verona, Italy., Mafficini A; ARC-NET Applied Research On Cancer Center, University of Verona, Verona, Italy.; Department of Engineering for Innovation Medicine (DIMI), University of Verona, Verona, Italy., Verschuur AVD; Department of Pathology, UMC Utrecht, Utrecht, the Netherlands., Calicchia M; ARC-NET Applied Research On Cancer Center, University of Verona, Verona, Italy., Hackeng WM; Department of Pathology, UMC Utrecht, Utrecht, the Netherlands., Simbolo M; Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Piazzale L.A. Scuro, 10, 37134, Verona, Italy., Paiella S; Department of General and Pancreatic Surgery, The Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy., Dreijerink KMA; Department of Endocrinology, Amsterdam UMC, Amsterdam, the Netherlands.; Department of Pathology, UMC Utrecht, Utrecht, the Netherlands., Landoni L; Department of General and Pancreatic Surgery, The Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy., Pedron S; Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Piazzale L.A. Scuro, 10, 37134, Verona, Italy., Cingarlini S; Unit of Oncology, University and Hospital Trust of Verona, Verona, Italy., Salvia R; Department of General and Pancreatic Surgery, The Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy., Milella M; Department of Engineering for Innovation Medicine (DIMI), University of Verona, Verona, Italy.; Unit of Oncology, University and Hospital Trust of Verona, Verona, Italy., Lawlor RT; ARC-NET Applied Research On Cancer Center, University of Verona, Verona, Italy.; Department of Engineering for Innovation Medicine (DIMI), University of Verona, Verona, Italy., Valk GD; Department of Endocrine Oncology, UMC Utrecht, Utrecht, the Netherlands., Vriens MR; Department of Endocrine Surgery, UMC Utrecht, Utrecht, the Netherlands., Scarpa A; Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Piazzale L.A. Scuro, 10, 37134, Verona, Italy. aldo.scarpa@univr.it.; ARC-NET Applied Research On Cancer Center, University of Verona, Verona, Italy. aldo.scarpa@univr.it., Brosens LA; Department of Pathology, UMC Utrecht, Utrecht, the Netherlands. l.a.a.brosens@umcutrecht.nl.; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands. l.a.a.brosens@umcutrecht.nl., Luchini C; Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Piazzale L.A. Scuro, 10, 37134, Verona, Italy. claudio.luchini@univr.it.; ARC-NET Applied Research On Cancer Center, University of Verona, Verona, Italy. claudio.luchini@univr.it. |
| Source: | Endocrine pathology [Endocr Pathol] 2024 Dec; Vol. 35 (4), pp. 354-361. Date of Electronic Publication: 2024 Sep 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Humana Press Country of Publication: United States NLM ID: 9009288 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-0097 (Electronic) Linking ISSN: 10463976 NLM ISO Abbreviation: Endocr Pathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1559-0097 |
|---|---|
| DOI: | 10.1007/s12022-024-09826-z |
